GW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy Subjects

NCT06964711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: GW117 ODT
DRUG: Placebo

Sponsor

Beijing Greatway Pharmaceutical Technology Co.,Ltd.